Specializing in AI-driven precision medicine, the company develops advanced diagnostic tools and data analytics platforms to optimize treatment decisions for cancer and other complex diseases. Its innovative approach has attracted significant investor interest, positioning it as a key player in the intersection of healthcare and technology.
2 members of Congress have disclosed 3 trades in Tempus AI, Inc. (TEM), a Healthcare company. The buy/sell breakdown shows 3 purchases versus 0 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2026-01-16 | Nancy Pelosi | buy | $50K – $100K |
| 2025-05-09 | Rob Bresnahan | buy | $1K – $15K |
| 2025-01-14 | Nancy Pelosi | buy | $50K – $100K |